Bard Davol
Key Highlights
- Bard Davol has a rich history dating back to 1874, establishing it as a trusted name in the medical device industry.
- The company is a market leader in soft tissue reconstruction solutions, offering a comprehensive range of products for hernia repair and surgical procedures.
- Bard Davol is committed to innovation, with a dedicated team of researchers constantly expanding its product line to meet the needs of healthcare professionals.
- The company's focus on reliability and value has made it a preferred choice among clinicians, physicians, and patients.
- As a subsidiary of C.R. Bard, Inc., Bard Davol benefits from a strong parent company, enhancing its operational strengths and market presence.
About Bard Davol
Bard Davol is a renowned medical device company founded in 1874 in Providence, RI. Specializing in soft tissue reconstruction solutions, Bard Davol has been a market leader for the past 40 years, offering products for hernia repair, surgical procedures, and biologic implants. As a subsidiary of C.R. Bard, Inc., the company continues to innovate with a range of mesh prosthetics, surgical instruments, and techniques for hernia repair and other medical procedures.
Bard Davol's commitment to research and development is evident in its expanding portfolio of soft tissue repair, hemostasis, and performance irrigation products. Their products are designed to provide exceptional reliability and value, making them a trusted choice among clinicians, physicians, and patients.
With a team of dedicated researchers and a focus on innovation, Bard Davol remains at the forefront of the medical device industry, continually enhancing its offerings to meet the evolving needs of the healthcare sector.
Company Facts
| Ownership Private Company |
| Revenue 50Mto100M |
| Funding 0 |
| Parent Company C. R. Bard, Inc. (BD) |
Office Locations
- Providence, RI
Why Contact Bard Davol?
B2B professionals should contact Bard Davol for access to innovative medical device solutions and potential partnerships in the soft tissue reconstruction and surgical procedures markets. Their extensive product range and commitment to reliability make them a valuable partner for healthcare providers and medical device companies.
Who Should Contact Bard Davol for Business?
Sales teams selling medical devices, recruiters seeking roles in the medical device industry, and partners offering surgical instruments and biologic implants should reach out to Bard Davol.
Categories
- Medical Devices
- Surgical Instruments
- Biologic Implants
- Hernia Repair
- Soft Tissue Reconstruction
- Surgical Procedures
- Medical Innovation
- Healthcare Solutions
- Clinical Reliability
- Patient Value
Similar Companies
Companies that compete with or operate in similar markets to Bard Davol:
- TELA Bio
- Deep Blue Medical Advance
- Via Surgical
More Medical Devices Companies
Frequently Asked Questions
- What does Bard Davol do?
- Bard Davol is a medical device company specializing in soft tissue reconstruction solutions, including products for hernia repair, specialized surgical procedures, fixation, and biologic implants.
- How many employees does Bard Davol have?
- Bard Davol employs between 250 and 499 people.
- Where is Bard Davol headquartered?
- Bard Davol is headquartered in Warwick, Rhode Island, United States.
- What industry is Bard Davol in?
- Bard Davol operates in Medical Devices, Surgical Instruments, Biologic Implants.
- When was Bard Davol founded?
- Bard Davol was founded in 1874.
- Is Bard Davol still active?
- Yes, Bard Davol was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to Bard Davol?
- Research Bard Davol's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to Bard Davol?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with Bard Davol